Strategic exits Otium has a track record of acquiring and later selling portfolio assets, including the sale of Dental Company to Metric Capital Partners. This indicates a potential for future exit-driven collaboration or co-investment opportunities with firms seeking return-focused deals and structured exit strategies.

Growth leadership Recent leadership expansion signals a growth trajectory and appetite for scale. Engaging with Otium through strategic partnerships, co-investments, or advisory services could align with their growth phase and leadership recruitment priorities.

Tech and AI emphasis Active investments in technology-focused companies such as Comet Software and VSORA highlight a preference for tech-enabled, AI and software-driven ventures. This suggests receptive opportunities in high-growth software, AI hardware, and related platforms.

Private capital network Otium operates as a long-term investment platform with collaborations across notable funds and founders. There may be cross-portfolio opportunities for fundraising support, co-investment syndication, and access to a refined European growth-stage deal flow.

Market expansion potential Past acquisitions in the European dental sector and ongoing international activity imply openness to sector consolidation plays and market-expansion initiatives. BD efforts could target regional roll-ups, franchise networks, or platform plays in aligned sectors.